Project Description

Cerebrolysate

solution for injections – Cerebrolysatum

international nonproprietary name

Not established

Ref

BP-0022

Pharmacotherapeutic group

Nootropic preparations.

Composition of the preparation

Cerebrolysateis a hydrolysate of cattle brain, it contains free amino acids and peptides. Aminoacid composition ofcerebrolysateis varied in the following limits in milligrams per milliliter (mg/ml): L-lysine – 1,9±0,95; L-histidine – 0,6±0,30; L-arginine – 1,7±0,90; aspartic acid – 1,8±0,80; L-threonine – 1,4±0,70; serine – 2,3±0,95; L-glutamic acid – 5,0±1,25; L-alanine – 3,5±1,75; a L-proline – 1,2±0,50; glycine – 1,4±0,70; L-valine – 2,7±1,35; L-methionine – 1,3±0,65; L-leucine – 4,0±2,00; L-phenylalanine – 1,0±0,50; isoleucine – 2,2±1,40; tyrosine – 0,4±0,25.

Pharmacological action

Pharmacodynamics

Cerebrolysateincreases synthesis of proteins in nervous cells, raises resistance of brain tissue to an intoxication, hypoxia, hypoglycemia, mechanical trauma. The preparation activates integrative processes in the central nervous system, improves concentration of attention, processes of storing and reproducing of the information.

Pharmakokinetics

The pharmacokinetic analysis is difficult owing to complex structure of Cerebrolysate, including the sum of free amino acids and peptides.

Indications 

Cerebrolysate is applied in adult patients with impairment of CNS cortical functions caused by disturbances of a cerebral circulation, at dyscirculatory encephalopathy and in patients with  posttraumatic asthenic syndrome.

special indication

Application at pregnancy and lactation:special researches of safety of Cerebrolysateapplication at pregnancy and lactemias were not carried out. There are indications on undesirability of the preparation administration in the Ist  trimester of pregnancy.

special warning

Not established

Dosage and method of administration

The preparation is administrated under doctor prescription.

Cerebrolysateisintroduced intramusculary per 1-5 ml daily or every other day; course of treatment is 20-30 injections.

After 3-6 month interval the course of Cerebrolysatetreatment can be repeated.

overdosage

The phenomena of overdosage at application of the preparation are not described till now.

safety measures

Extra care should be kept at application in patients with acute renal failure. The preparation is administrated with care at allergic diathesis, severe convulsive seizures.

Side effects

Injections of a preparation are painful, the irritation of tissues in a place of injection is possible in seldom cases. A rising of arterial pressure can take place at idiopathic hypertensia of II-III severity during Cerebrolysatetreatment.

Contraindications

Relative contraindication to Cerebrolysate administrationis presence of allergic reactions in anamnesis. In these cases the introduction of a preparation is spent under direct observation of a doctor.

Interactions with other medicinal preparations

It was not reported till now on undesirable reactions at combined application of Cerebrolysatewith other medical products.

The form of release

Solution for injections in 1 ml ampoules. 10 ampoules in a box.